Changes in the Expression Profile of VEGF-A, VEGF-B, VEGFR-1, VEGFR-2 in Different Grades of Endometrial Cancer.

CONCLUSION: VEGF-A, VEGF-B, VEGF-R1, VEGFR-2 are key proteins involved in tumor angiogenesis. The analysis of the entire panel of proteins involved in a given process is an important element of modern diagnostics. The concentration ratio of VEGFR-1 to VEGFR-2 appears to be a determining factor in the patients' survival prognosis. PMID: 31322068 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31322068?dopt=Abstract

Source: Current Pharmaceutical Biotechnology - July 15, 2019 Category: Biotechnology Authors: Dziobek K, Opławski M, Grabarek B, Zmarzły N, Tomala B, Halski T, Leśniak E, Januszyk K, Brus R, Kiełbasiński R, Boroń D Tags: Curr Pharm Biotechnol Source Type: research